The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions - Trial NCT06244407
Access comprehensive clinical trial information for NCT06244407 through Pure Global AI's free database. This Phase 1 trial is sponsored by International Bio service and is currently Not yet recruiting. The study focuses on Healthy Volunteer. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Vildagliptin and Metformin Hydrochloride 50mg 1000 mg Film-coated Tablets
Interventional
drug
Sponsor & Location
International Bio service
Timeline & Enrollment
Phase 1
May 23, 2024
Jun 02, 2024
Primary Outcome
Plasma Area Under the Curve (AUC(0 to 36hr)) for Vildagliptin and Metformin
Summary
To determine and compare the rate and extent of absorption of a test formulation with that of
 a reference innovator formulation when given as equal labeled dose in healthy subjects under
 fed conditions
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06244407
Non-Device Trial